Replicate’s rabies vaccine demonstrates effectiveness in Phase I trial

Submitted by admin on February 14, 2024 - 6:37pm

Source:

Clinical Trials Arena

News Tags:

Headline:

snippet:

RBI-4000 induced neutralising antibody titres at levels that exceeded the WHO’s defined surrogate level of protection for rabies virus.

Search form